Introducing Varithena! A nearly painless way to treat varicose veins and vein disease.

Introducing Varithena! A nearly painless way to treat varicose veins and vein disease.

A non-surgical treatment for varicose veins

Varithena, approved by the FDA in 2013, is an clinically proven treatment for varicose veins that combines guided ultrasound with an injectable microfoam is now available for patients at Advanced Vein Center. Currently, it is the only therapy of its kind to have received FDA approval. Varithena effectively improves the appearance of varicose veins caused by vein disease and diseased superficial veins as well as symptoms such as heaviness, achiness, swelling, throbbing and itching (HASTI™ symptoms)1.

When Varithena (1% polidocanol injectable foam) is introduced into a diseased vein via guided ultrasound, the blood within is displaced and the vein begins to collapse. This collapse of the vein stops the backflow of blood from occurring and redirects blood upward and into nearby healthy veins that can handle the optimal flow. After the office treatment, patients can return home and resume most activities the same day. The over 300,000+ Varithena treatments, 12 clinical studies and 25+ peer-reviewed publications demonstrate Varithena’s proven safety and effectiveness2.

For more information, contact us or call/text 724-987-3220.

Before & After

Before & After Varithena

Frequently Asked Questions

Chronic venous insufficiency is a type of vein disease in which veins have increased pressure and are unable to allow blood to flow back up from your legs to your heart. Veins have valves that prevent blood from flowing in the wrong direction. However, when these valves don’t work well, the blood flows backwards, causing the blood to pool in your legs. If you have chronic venous insufficiency, you might have varicose veins, edema or leg swelling or even venous leg ulcers.1

Varicose veins and vein disease are enlarged, often bluish, twisting leg veins that bulge above the surface of the skin. It is a common condition affecting many men and women. They can cause uncomfortable symptoms such as heaviness, achiness, swelling, throbbing and itching (HASTI™).

Spider veins are smaller and look more like branching veins and can be found on the legs or face. Typically, spider veins are not accompanied by the HASTI symptoms. Your doctor can determine if spider veins have underlying vein issues that could lead to varicose veins.

Varicose veins occur when one-way valves that regulate the direction of blood flow become weakened and no longer function properly. Instead of blood moving toward the heart, weakened vein valves can cause blood to leak back into the veins causing them to enlarge.

Varicose veins can and often do get worse if left untreated. In the Edinburgh Vein Study, chronic venous disease progressed in more than 57% of the patients with varicose veins or chronic venous insufficiency over 13 years of follow-up.2

Common risk factors include family history, aging, gender, pregnancy, being overweight, lack of movement, history of deep vein thrombosis and working at jobs requiring prolonged standing.

Venous leg ulcers are a symptom of advanced chronic venous insufficiency. Certain factors put you at increased risk for venous leg ulcers, including varicose veins, obesity, standing for long periods of time (usually for work) and having a history of blood clots in your legs. 1 in 4 Americans 65 and over will have a venous leg ulcer in their lifetime.3

Venous leg ulcers are caused by high pressure in the lower leg veins, called venous hypertension. When this pressure continues, it damages the skin, which breaks down and forms an ulcer. Symptoms of venous leg ulcers Venous leg ulcers can be unsightly and painful wounds that develop around your ankle. They typically look like large, shallow wounds with uneven edges. Other symptoms4 can include achiness, swelling, throbbing, itching and skin changes.

1 National Institutes of Health. Venous Insufficiency. MedlinePlus website. Accessed February 2023.
2 Lee et al. J Vasc Surg Venous Lymphat Disord. 2015;3(1):18–26.
3 Margolis et al. J Am Acad Dermatol. 2002;46(3):381-386.